AI assistant
Sending…
EXELON CORP — Director's Dealing 2022
Oct 3, 2022
30044_dirs_2022-10-03_a1ddf3d1-bc37-4c60-bc83-5c8c56067113.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELON CORP (EXC)
CIK: 0001109357
Period of Report: 2022-09-30
Reporting Person: Cheshire Marjorie Rodgers (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-09-30 | Common Stock (Deferred Stock Units) | A | 845 | $45.84 | Acquired | 9368 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | Deferred Compensation - Phantom Share Equivalents | $ | A | 383 | Acquired | Common Stock (383) | Direct |
Footnotes
F1: Balance includes 62 shares acquired on September 9, 2022 through automatic dividend reinvestment.
F2: Phantom share equivalents in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 21 share equivalents accrued on August 12, 2022 through automatic dividend reinvestment.
More from EXELON CORP
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 16
Annual Report
2026
Mar 18
Regulatory Filings
2026
Mar 18
Proxy Solicitation & Information Statement
2026
Mar 18
Regulatory Filings
2026
Feb 20
Regulatory Filings
2026
Feb 12
Annual Report
2026
Feb 12
Director's Dealing
2026
Feb 4